Hormonal replacement therapy in menopausal women with a history of hyperprolactinemia

Journal of Endocrinological Investigation

Volumn 21, Issue 11, 1998, Pages 732-736

  Touraine, P ^a   Deneux, C ^a   Plu Bureau, G ^a   Mauvais Jarvis, P ^a   Kuttenn, F ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Hormonal replacement therapy; Hyperprolactinemia; Menopause; Prolactin

Indexed keywords

BROMOCRIPTINE; ESTRADIOL; ESTROGEN; GESTAGEN; PROLACTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HYPERPROLACTINEMIA; MENOPAUSE; PROLACTIN BLOOD LEVEL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

EID: 0032407059     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03348037     Document Type: Article

References (18)

1. Molitch M.E. Pregnancy and the hyperprolactinemic woman. N. Engl. J. Med. 312: 1365, 1985.
2. Maurer R.A. Estradiol regulates the transcription of the prolactin gene. J. Biol. Chem. 257: 2133, 1982.
3. Lieberman M.E, Maurer R.A., Gorski J. Estrogen control of prolactin synthesis in vitro. Proc. Natl. Acad. Sci. USA. 75: 5946, 1978.
4. Vrontakis M.E., Thliveris J.A, Friesen H.G. Influence of bromocriptine and oestrogen on prolactin synthesis, secretion and tumour growth in vivo in rats. J. Endocrinol. 113: 383, 1987.
5. Franchimont P., Dourcy C., Legros J.J., Reuter A., . Vrindts-Gevaert Y., Van Cauwenberge J.R., Gaspard U. Prolactin levels during the menstrual cycle. Clin. Endocrinol. (Oxf.). 5: 643, 1976.
6. Vekemans M., Robyn C. Influence of age on serum prolactin levels in women and men. Br. Med. J. 4: 738, 1975.
7. Rozenberg S., Bosson D., Peretz A., Caufriez A., Robyn C. Serum levels of gonadotrophins and steroid hormones in the postmenopause and later life. Maturitas 10: 215, 1988.
8. Notelovitz M., Ware M.D., Buhi W.C., Dougherty M.C. Prolactin: effects of age, menopausal status, and exogenous hormones. Am. J. Obstet. Gynecol. 143: 225, 1982.
9. Metka M., Holzer G., Raimann H., Heytmanek G., Hartmann B., Kurz Ch. The role of prolactin in the menopause. Maturitas 20: 151, 1995.
10. Shy K.K., McTiernan A.M., Daling J.R., Weiss N.S. Oral contraceptive use and the occurence of pituitary prolactinoma. JAMA 249: 2204, 1983.
11. Maheux R., Jenicek M., Cleroux R., Beauregard H., De Muylder X, Gratton N.M., Van Campenhout J. Oral contraceptives and prolactinomas: a case-control study. Am. J. Obstet. Gynecol. 143: 134, 1982.
12. Corenblum B., Donovan L. The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia. Fertil. Steril. 59: 671, 1993.
13. Fahy U.M., Foster P.A., Torode H.W., Hartog M., Hull M.G.R. The effect of combined estrogen/progestogen treatment in women with hyperprolactinemic amenorrhea. Gynecol. Endocrinol. 6: 183, 1992.
14. Schlechte J., Dolan K., Sherman B., Chapler F., Luciano A. The natural history of untreated hyperprolactinemia: a prospective analysis. J. Clin. Endocrinol. Metab. 68: 412, 1989.
15. Martin T.L, Kim M., Malarkey W.B. The natural history of idiopathic hyperprolactinemia. J. Clin. Endocrinol. Metab. 60: 855, 1985.
16. Jeffcoate W.J., Pound N., Sturrock N.D.C., Lambourne J. Long term follow-up of patients with hyperprolactinemia. Clin. Endocrinol. (Oxf.) 45: 299, 1996.
17. Haug E. Progesterone suppression of estrogen-stimulated prolactin secretion and estrogen receptor levels in rat pituitary cells. Endocrinology 104: 429, 1979.
18. Bression D., Brandi A.M., Pagesy P., Le Dafniet M., Martinet M., Brailly S., Michard M., Peillon F. In vitro and in vivo antagonistic regulation by estradiol and progesterone of the rat pituitary domperi-done binding sites: correlation with ovarian steroid regulation of the dopaminergic inhibition of prolactin secretion in vitro. Endocrinology 116: 1905, 1985.